Roginolisib

DB18088InvestigationalSmall molecule

Roginolisib: Overview.

Mechanism: Pharmacologically active on Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
Curator reviewed
Formula / weight: C₂₆H₂₇FN₄O₅S · 526.58 g/mol (avg)
Code names: IOA-244 · MSC-2360844

Resolves to

Compound

Structure

InChIKeyNFHSJYKXENYICE-UHFFFAOYSA-NSMILESFC1=CC=CC2=C1S(=O)(=O)CC1=C2N(N=C1C(=O)N1CCOCC1)C1=CC=C(CN2CCOCC2)C=C1

Targets

What you can answer from here — as of September 12, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

8Clinical trialsPhase, status and sponsor resolved per trial

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with Roginolisib, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.